The shares of Q-Line Biotech IPO are commanding a strong premium in the grey market. According to Investorgain, the GMP of Q-Line Biotech IPO is ₹115 in the grey market.
Recent Posts
- Solarworld Energy Q4 Results: Profit Soars Over 5x To Rs 49 Crore, Revenue Triples
- Is JD Vance Getting Isolated After Tulsi Gabbard’s Exit Amid Marco Rubio’s Rise? Here’s What Reports Say
- Stock Market News Today Live Updates: Nifty Below 23,400 Amid F&O Expiry, Sensex Falls 500 Points From Day’s High; HDFC Bank, RIL Top Losers
- Better Earnings Next Quarter: Helios Capital CEO Dinshaw Irani Raises FY27 Growth Outlook
- Mumbai University First Merit List 2026 Released; Check Mithibai, Thakur, Sophia, St. Xavier’s College-Wise Merit List